Abstract
Delivery systems with a pulsatile-release method are particularly involved in designing medicines for which traditional managed drug-release systems with the continuous release are not suitable. This medication also has a high first-pass impact or special conditions for chrono-pharmacology. These medications also have a high first-pass or unique chronopharmacological effect. The pulsatile release profile is characterised by a duration of no release (lag time) followed by a fast and full release of the drug. Pulsatile drug delivery systems may be classified into site-specific systems in which the drug is released inside the gastrointestinal system (e. g. colon) or time-controlled devices wherein the drug is released after a well-defined time period. Site-regulated release is typically controlled by environmental factors, such as pH or enzymes found in the intestinal tract, whereas drug release from time-controlled processes is controlled mainly by the delivery system and, preferably, not by the environment. This review covers various single-and multiple-unit oral pulsatile drug-delivery systems with an emphasis on time-controlled drug-release systems.
Highlights
The circadian behaviour of the disease helps the medicine to release in pulsatile form
Circadian rhythm is based on the daily routine which is include sleep activity, and it is affected by modern gene structure of human and at the end it alters the body’s function day and night
Due to advance technology and availability of all necessary requirements pharmaceutical field grow at fast rate and develop such kind of formulation which release in particular manner by following the circadian behaviour of the body
Summary
The circadian behaviour of the disease helps the medicine to release in pulsatile form. Single unit system is developed by the use of erodible or breakable coating on core material; it is either in capsule form or in osmotic based type formulation. As shown in table 2 various types of pulsatile drug delivery systems are as follows
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Current Pharmaceutical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
